Correction to: Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients (Arthritis Research & Therapy, (2021), 23, 1, (5), 10.1186/s13075-020-02372-z)

Abstract

Following publication of the original article [1], a typesetting error was reported. The affiliations for Sujatha Muralidharan and Natalia V. Giltiay are as follows: Sujatha Muralidharan: Kiniksa Pharmaceuticals Corp, Lexington, MA 02421, USA Natalia V. Giltiay: Division of Rheumatology, Department of Medicine, School of Medicine, University of Washington, 750 Republican St, Seattle, WA 98109, USA The original article [1] has been corrected.